Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.69 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.58 |
| ▸ | PAM | P19021 | 2/20 | 0.53 |
| ▸ | PLA2G4B | P0C869 | 2/20 | 0.51 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.50 |
| ▸ | PPARG | P37231 | 6/20 | 0.50 |
| ▸ | PPARD | Q03181 | 6/20 | 0.50 |
| ▸ | PPARA | Q07869 | 6/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.50 |
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TLR2 | O60603 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | FABP4 | P15090 | 2/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.50 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4651569 | 1.00 | CES2 (0.69) | CES2EPHX2PAMPLA2G4BGPR84 | |
| SCHEMBL7249862 | 1.00 | CES2 (0.69) | CES2EPHX2PAMPLA2G4BGPR84 | |
| SCHEMBL8198788 | 1.00 | CES2 (0.69) | CES2EPHX2PAMPLA2G4BGPR84 | |
| SCHEMBL501889 | 1.00 | CES2 (0.69) | CES2EPHX2PAMPLA2G4BGPR84 | |
| SCHEMBL21611691 | 1.00 | CES2 (0.69) | CES2EPHX2PAMPLA2G4BGPR84 | |
| SCHEMBL7763197 | 1.00 | CES2 (0.69) | CES2EPHX2PAMPLA2G4BGPR84 | |
| SCHEMBL3296171 | 1.00 | CES2 (0.69) | CES2EPHX2PAMPLA2G4BGPR84 | |
| SCHEMBL8626082 | 1.00 | CES2 (0.69) | CES2EPHX2PAMPLA2G4BGPR84 | |
| SCHEMBL21611665 | 1.00 | CES2 (0.69) | CES2EPHX2PAMPLA2G4BGPR84 | |
| SCHEMBL7611940 | 1.00 | CES2 (0.69) | CES2EPHX2PAMPLA2G4BGPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113827738-B | Sialic acid modified dexamethasone palmitate liposome and preparation and application thereof | 沈阳药科大学 | 2024-04-09 | — | — | CN | claimed |
| CN-113827738-B | Sialic acid modified dexamethasone palmitate liposome and preparation and application thereof | 沈阳药科大学 | 2024-04-09 | — | — | CN | disclosed |
| CN-113827738-B | Sialic acid modified dexamethasone palmitate liposome and preparation and application thereof | 沈阳药科大学 | 2024-04-09 | — | — | CN | disclosed |
| CN-113827738-A | Sialic acid modified dexamethasone palmitate liposome and preparation and application thereof | 沈阳药科大学 | 2021-12-24 | — | — | CN | disclosed |
| US-9663444-B2 | Heteroatom containing substituted fatty acids | COMPLEXA, INC. (US) | 2017-05-30 | — | — | US | disclosed |
| US-20170113999-A9 | HETEROATOM CONTAINING SUBSTITUTED FATTY ACIDS | COMPLEXA, INC. (US) | 2017-04-27 | — | — | US | disclosed |
| US-20140256814-A1 | HETEROATOM CONTAINING SUBSTITUTED FATTY ACIDS | COMPLEXA, INC. (US) | 2014-09-11 | — | — | US | disclosed |
| EP-2483233-A2 | HETEROATOM CONTAINING SUBSTITUTED FATTY ACIDS | Miller, Raymond A. (US) | 2012-08-08 | — | — | EP | disclosed |
| WO-2011041639-A2 | HETEROATOM CONTAINING SUBSTITUTED FATTY ACIDS | MILLER RAYMOND A (US) | 2011-04-07 | — | — | WO | disclosed |
| US-20110082206-A1 | HETEROATOM CONTAINING SUBSTITUTED FATTY ACIDS | COMPLEXA, INC. | 2011-04-07 | — | — | US | disclosed |
| EP-1970409-A1 | Compositions for articles comprising replicated microstructures | GENERAL ELECTRIC COMPANY (US) | 2008-09-17 | — | — | EP | disclosed |
| EP-1828319-A1 | COMPOSITIONS FOR ARTICLES COMPRISING REPLICATED MICROSTRUCTURES | General Electric Company (US) | 2007-09-05 | — | — | EP | disclosed |
| US-20070082988-A1 | Compositions for articles comprising replicated microstructures | GENERAL ELECTRIC COMPANY (US) | 2007-04-12 | — | — | US | disclosed |
| WO-2006065542-A1 | COMPOSITIONS FOR ARTICLES COMPRISING REPLICATED MICROSTRUCTURES | GENERAL ELECTRIC COMPANY (US) | 2006-06-22 | — | — | WO | disclosed |
| US-20060128853-A1 | Compositions for articles comprising replicated microstructures | GENERAL ELECTRIC COMPANY (US) | 2006-06-15 | — | — | US | disclosed |
| EP-0262399-B1 | CYCLIC ENOL DERIVATIVES, PRODUCTION AND USE THEREOF | Takeda Chemical Industries, Ltd. (JP) | 1993-02-03 | — | — | EP | disclosed |
| US-4925868-A | CARDIOVASCULAR DISORDERS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1990-05-15 | — | — | US | disclosed |
| EP-0262399-A2 | Cyclic enol derivatives, production and use thereof | Takeda Chemical Industries, Ltd. (JP) | 1988-04-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170113999-A9 | HETEROATOM CONTAINING SUBSTITUTED FATTY ACIDS | FFAR2, FFAR1, FFAR4 | CES2 547/4885EPHX2 279/4885PAM 637/4885 |
| US-20140256814-A1 | HETEROATOM CONTAINING SUBSTITUTED FATTY ACIDS | FFAR2, FFAR1, FFAR4 | CES2 547/4885EPHX2 279/4885PAM 637/4885 |
| US-20110082206-A1 | HETEROATOM CONTAINING SUBSTITUTED FATTY ACIDS | FFAR2, FFAR1, FFAR4 | CES2 547/4885EPHX2 279/4885PAM 637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.